Literature DB >> 12617959

Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain.

C E Hagemeyer1, H Rosenbrock, M Ditter, R Knoth, B Volk.   

Abstract

Despite the very small amounts of cytochrome P450 enzymes expressed in different areas and cell populations of the brain as compared with the liver, there is significant evidence for their specific involvement in brain development, function, and plasticity. Nevertheless, the current discussion about occurrence and importance of cerebral cytochrome P450 isoforms is determined by controversial interpretations of their function in general and with respect to single isoforms. Continuing a series of publications about brain P450 isoforms, we now present evidence for the expression of cytochrome P450 3A11 and 3A13 in mouse brain. Immunocytochemical and non-radioactive in situ hybridization studies revealed identical distribution of their proteins and mRNAs throughout the brain especially in neuronal populations, and to some extent in astrocytes. The cerebral expression of these P450 isoforms was confirmed by Western blot and RNAse protection assay analysis. The well-known testosterone-metabolizing capacity and the inducibility of cytochrome P450 3a isoforms by xenobiotics as well as their presence in steroid hormone-sensitive areas and neurons (e.g. hippocampus) clarify the significance of these isoforms for impairment of steroid hormone actions by P450-inducing environmental substances. Therefore, investigation of inducible cerebral P450 isoforms which are able to metabolize xenobiotics as well as steroid hormones might help us to understand neuroendocrine regulation of brain's plasticity. Copyright 2003 IBRO

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12617959     DOI: 10.1016/s0306-4522(02)00955-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

1.  Neurobehavioral abnormalities in a brain-specific NADPH-cytochrome P450 reductase knockout mouse model.

Authors:  C Fang; V J Bolivar; J Gu; W Yang; S O Zeitlin; X Ding
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

Review 2.  Cytochrome P450-mediated drug metabolism in the brain.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

Review 3.  Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.

Authors:  Chaitali Ghosh; Vikram Puvenna; Jorge Gonzalez-Martinez; Damir Janigro; Nicola Marchi
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

Review 4.  Statins and neuroprotection: basic pharmacology needed.

Authors:  W Gibson Wood; Walter E Mΰller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2014-01-29       Impact factor: 5.590

5.  Cytochrome P4503A: evidence for mRNA expression and catalytic activity in rat brain.

Authors:  Sanjay Yadav; Alok Dhawan; Prahlad K Seth; Ram L Singh; Devendra Parmar
Journal:  Mol Cell Biochem       Date:  2006-05-04       Impact factor: 3.396

6.  Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs.

Authors:  Annalisa Nannelli; Francesco Rossignolo; Roberto Tolando; Paolo Rossato; Mario Pellegatti; Vincenzo Longo; P Giovanni Gervasi
Journal:  Mol Cell Biochem       Date:  2009-10-22       Impact factor: 3.396

7.  Differences in the expression and inducibility of cytochrome P450 2B isoenzymes in cultured rat brain neuronal and glial cells.

Authors:  Nidhi Kapoor; Aditya B Pant; Alok Dhawan; Uppendra N Dwievedi; Prahlad K Seth; Devendra Parmar
Journal:  Mol Cell Biochem       Date:  2007-07-24       Impact factor: 3.396

8.  Fexofenadine brain exposure and the influence of blood-brain barrier P-glycoprotein after fexofenadine and terfenadine administration.

Authors:  Rong Zhao; J Cory Kalvass; Souzan B Yanni; Arlene S Bridges; Gary M Pollack
Journal:  Drug Metab Dispos       Date:  2008-12-29       Impact factor: 3.922

9.  Tissue Distribution and Gender-Specific Protein Expression of Cytochrome P450 in five Mouse Genotypes with a Background of FVB.

Authors:  Jiamei M Chen; Qisong S Zhang; Xiaoyan Y Li; Xia Gong; Yanjiao J Ruan; Sijing J Zeng; Linlin L Lu; Xiaoxiao X Qi; Ying Wang; Ming Hu; Lijun J Zhu; Zhongqiu Q Liu
Journal:  Pharm Res       Date:  2018-04-10       Impact factor: 4.200

Review 10.  Pathophysiological implications of neurovascular P450 in brain disorders.

Authors:  Chaitali Ghosh; Mohammed Hossain; Jesal Solanki; Aaron Dadas; Nicola Marchi; Damir Janigro
Journal:  Drug Discov Today       Date:  2016-06-14       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.